Vitae Pharmaceuticals - Articles and news items

Type 2 diabetes

Boehringer Ingelheim and Vitae type 2 diabetes drug misses endpoint

Industry news / 1 July 2015 / Victoria White

Vitae has announced top-line efficacy results from the metformin arm of a trial of BI187004/VTP-34072 in the treatment of patients with type 2 diabetes…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+